DEF 14C

DEF 14C Filing

Company: Shuttle Pharmaceuticals Holdings, Inc.
Filed: February 13, 2023
Period of Report: February 13, 2023
Accession Number: 0001493152-23-004519

View Document ↗ View on SEC.gov ↗